Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Telomeres in mitosis: organization and dynamics. | Nucleus | 2026 | 42758105 | PubTator, text mining | PubMed |
| An Integrated Consensus Machine Learning and Structure-Based Workflow for the Discovery of Novel Tankyrase 1 Inhibitors. | Pharmaceuticals (Basel) | 2026 | 42653805 | PubTator, text mining | PubMed |
| Tankyrase-2 regulates adipocyte differentiation through AMPK/mTOR signaling. | FEBS J | 2026 | 42563506 | PubTator, text mining | PubMed |
| Replacement soaking for human tankyrase 2 enables studies on substrate analogues and inhibitors. | Acta Crystallogr D Struct Biol | 2026 | 42522928 | PubTator, text mining | PubMed |
| Disrupting the tumor-associated TNKS-USP25 protein-protein interface in cancer: structural basis, druggability, and therapeutic opportunities. | RSC Adv | 2026 | 42441110 | PubTator, text mining | PubMed |
| Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis. | Mol Biol Rep | 2026 | 42423804 | PubTator, text mining | PubMed |
| FMRP-Mediated Proteasome Regulation: A Novel Mechanism in ALS Pathology. | FASEB J | 2026 | 42363684 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of Novel Flavone-Sulfonamide Hybrid Derivatives as Potential Anticancer Agents. | Curr Med Chem | 2026 | 42300302 | PubTator, text mining | PubMed |
| Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer. | J Cell Mol Med | 2026 | 42286682 | PubTator, text mining | PubMed |
| Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression. | J Neurooncol | 2026 | 42257837 | PubTator, text mining | PubMed |
| Characterization and Cytotoxicity of West Java Coffee Extracts, Chlorogenic Acid, Caffeine on MDA-MB-231, MCF-7 Cell Lines, and Their Impact on MYC and AXIN2 Wnt Pathway Gene Expression. | Breast Cancer (Dove Med Press) | 2026 | 42221213 | PubTator, text mining | PubMed |
| Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesis. | Cell Commun Signal | 2026 | 42204589 | PubTator, text mining | PubMed |
| Benchmarking genome choice in functional genomics analyses. | Nat Commun | 2026 | 42185280 | PubTator, text mining | PubMed |
| JPI-547, a novel dual inhibitor of PARP1/2 and tankyrase is more effective than first-generation PARP inhibitors in preclinical BRCA1/2-mutated cancer models. | Br J Cancer | 2026 | 42092176 | PubTator, text mining | PubMed |
| Visualization and Quantitative Analysis of Genotoxin-induced PARP1/PARP2 Activation in Cells using a Fluorescent Fusion Protein-based Reporter. | J Vis Exp | 2026 | 42081377 | PubTator, text mining | PubMed |
| Pancreatic Lymphatics in Health and Disease: Evolution, Embryology, and Neural Control. | Lymphatics | 2026 | 42040173 | PubTator, text mining | PubMed |
| Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances. | Mol Biomed | 2026 | 41826571 | PubTator, text mining | PubMed |
| A comprehensive genome-wide scan for parent-of-origin expressed genes in the pig clarifies the conservation landscape of genomic imprinting. | Genet Sel Evol | 2026 | 41803684 | PubTator, text mining | PubMed |
| DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway. | Oncol Res | 2026 | 41799507 | PubTator, text mining | PubMed |
| PARP-2 catalytic activity drives replication-ICL repair in an allele-specific manner during germline development. | PLoS Genet | 2026 | 41785248 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers